-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Colgate-Palmolive, Lowers Price Target to $106

Benzinga·07/17/2025 14:16:33
Listen to the news
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and lowers the price target from $109 to $106.